Kirkland Signature Smoked Salmon products recalled in October 2024 are now considered to be a Class 1 recall, the FDA’s most ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Detailed price information for Nervgen Pharma Corp (NGEN-X) from The Globe and Mail including charting and trades.

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

As per the recent earnings update by FactSet dated 24th January 2025, the Q4 2024 earnings season for the S&P 500 has seen a ...

We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...

Trump agriculture secretary nominee Brooke Rollins says bird flu will be 'one of the very top priorities' for USDA if she is ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

An investigational, novel combination therapy, consisting of an N-methyl-D-aspartate receptor-modulating drug (ketamine) delivered intravenously (IV) in combination with manualized relapse prevention ...